Stocks
FibroGen (FGEN) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -164.3 | -274.8 | -288.5 | -282.8 | -261.4 | -99.9 | ||
| Changes by years, y/y, % | +214% | +67% | +5% | -2% | -8% | +28.3% | |||
FibroGen. EBITDA US GAAP, bln rub
FibroGen. EBITDA US GAAP, changes, %
FibroGen. EBITDA US GAAP, sum by quarters, bln rub
FibroGen (FGEN) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -56.8 | -49.8 | -27.7 | -10.1 | -12.2 | -99.9 | |
| Changes by years, y/y, % | -38% | -20% | -63% | -88% | -78% | |||
| Changes by quarters, q/q, % | -31% | -12% | -44% | -63% | +21% | |||
